CITED CLIPS

Cannabis and Pain Relief

Cannabis shows promise in reducing neuropathic pain, yet large-scale studies reveal mixed results regarding its effectiveness. The classification of cannabis as a Schedule One drug hampers research, despite evidence suggesting potential therapeutic benefits, particularly with specific THC and CBD ratios. Ongoing population-level experiments may illuminate the drug's impact, but challenges remain in understanding its true efficacy and safety.